BIFEPRUNOX vs placebo
Mental state: 1. Mean change PANSS positive subscale (lower value = good) · patients with schizophrenia
1 finding from 1 review
- no estimate extracted2 studies · 549 participantsLow
Findings
What do systematic reviews say?
7 questions · 7 findings · 1 reviews
No studies found 0 · 0%GRADE not reported 3 · 42.9%Very low 1 · 14.3%Low 2 · 28.6%Moderate 1 · 14.3%High 0 · 0%
BIFEPRUNOX vs placebo
Mental state: 2. Mean change PANSS negative subscale (lower value = good) · patients with schizophrenia
1 finding from 1 review
- no estimate extracted2 studies · 549 participantsLow
BIFEPRUNOX vs placebo
Re‐admission during · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
BIFEPRUNOX vs placebo
Global state: Deteriorated CGI · patients with schizophrenia
It is very uncertain whether BIFEPRUNOX changes global state: Deteriorated CGI compared with PLACEBO (very low certainty).
1 finding from 1 review
- RR 0.71 [0.54, 0.93]1 study · 231 participantsVery low
BIFEPRUNOX vs placebo
Quality of life: Important change · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
BIFEPRUNOX vs placebo
Weight gain · patients with schizophrenia
BIFEPRUNOX showed no clear difference in adverse effects: Weight ‐ Total number of participants with ≥ 7%… compared with PLACEBO (moderate certainty).
1 finding from 1 review
- RR 1.02 [0.31, 3.33]1 study · 483 participantsModerate
BIFEPRUNOX vs placebo
Costs · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported